Redwire Corp
For the period ended Dec 31, 2025. Filed Feb 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 27, 2026
RDW$8.13-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands of U.S. dollars)
| Year Ended | |||
|---|---|---|---|
| December 31, 2025 | December 31, 2024 | December 31, 2023 | |
| Cash flows from operating activities: | |||
| Net income (loss) | $(226,552) | $(114,311) | $(27,264) |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||
| Depreciation and amortization expense | 32,639 | 11,692 | 10,724 |
| Amortization of debt issuance costs and discount | 2,282 | 857 | 608 |
| Equity-based compensation expense | 58,990 | 11,326 | 8,658 |
| (Gain) loss on sale of joint ventures | — | (1,303) | — |
| Loss on extinguishment of debt | 996 | — | — |
| (Gain) loss on change in fair value of committed equity facility | — | — | 255 |
| (Gain) loss on change in fair value of warrants | (16,109) | 51,960 | 2,011 |
| Deferred provision (benefit) for income taxes | (24,901) | (1,803) | (925) |
| Impairment expense | 34,685 | — | — |
| Income from equity method investments | — | — | (245) |
| Non-cash lease expense | 488 | 227 | 327 |
| Non-cash interest expense | — | — | 525 |
| Purchase accounting fair value adjustment related to inventory | 13,645 | — | — |
| Other | (1,470) | 2,050 | (238) |
| Changes in assets and liabilities: | |||
| (Increase) decrease in accounts receivable | (2,321) | 14,670 | (5,562) |
| (Increase) decrease in contract assets | 863 | (7,138) | (5,442) |
| (Increase) decrease in inventory | (6,652) | (734) | (44) |
| (Increase) decrease in prepaid expenses and other assets | (4,386) | (1,793) | 229 |
| Increase (decrease) in accounts payable and accrued expenses | (11,660) | 4,365 | (3,280) |
| Increase (decrease) in deferred revenue | (33,980) | 3,207 | 22,736 |
| Increase (decrease) in operating lease liabilities | (232) | (342) | (325) |
| Increase (decrease) in other liabilities | 6,344 | 9,722 | (960) |
| Increase (decrease) in notes payable to sellers | — | — | (557) |
| Net cash provided by (used in) operating activities | (177,331) | (17,348) | 1,231 |
| Cash flows from investing activities: | |||
| Acquisition of businesses, net of cash acquired | (151,791) | (881) | — |
| Net proceeds from sale of joint ventures | — | 4,598 | — |
| Purchases of property, plant and equipment | (13,479) | (6,399) | (5,620) |
| Purchase of intangible assets | (9,801) | (4,517) | (2,707) |
| Net cash provided by (used in) investing activities | (175,071) | (7,199) | (8,327) |
| Cash flows from financing activities: | |||
| Proceeds received from debt | 191,131 | 45,971 | 36,696 |
| Repayments of debt | (234,165) | (8,863) | (26,683) |
| Payment of debt issuance fees | (105) | (780) | (163) |
| Repayment of finance leases | (534) | (479) | (395) |
| Proceeds from (repayment of) third-party advances | (7,820) | 7,820 | — |
| Proceeds from issuance of common stock | 518,370 | 2,669 | 1,241 |
| Payment of equity issuance costs | (1,749) | — | (571) |
| Payments of issuance costs related to convertible preferred stock | — | — | (52) |
| Shares repurchased for settlement of employee tax withholdings on share-based awards | (3,769) | (2,622) | (570) |
| Payment of contingent earnout | — | — | (443) |
| Repurchase of convertible preferred stock | (63,863) | — | — |
| Net cash provided by (used in) financing activities | 397,496 | 43,716 | 9,060 |
| Effect of foreign currency rate changes on cash, cash equivalents and restricted cash | 1,018 | (376) | (2) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 46,112 | 18,793 | 1,962 |
| Cash, cash equivalents and restricted cash at beginning of period | 49,071 | 30,278 | 28,316 |
| Cash, cash equivalents and restricted cash at end of period | $95,183 | $49,071 | $30,278 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.